News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN) Closes Deal With Financial Firm to Open New Biotech Company Atara Biotherapeutics


10/26/2012 10:10:56 AM

Amgen | Jobs at Amgen

Amgen and Kleiner Perkins Caufield & Byers (KPCB) have founded a new drug development firm, Atara Biotherapeutics, focused on chronic diseases in therapeutic areas including nephrology and oncology. Atara will start out with licenses to six of Amgen’s preclinical and early-clinical programs.

The new firm will initially be financed by KPCB, and headed by former KPCB partner, Isaac Ciechanover, M.D. Amgen will retain a minority equity interest in Atara.


comments powered by Disqus
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES